Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Volume 3D_US Kidney
Clinical trial update from Assistance Publique - Hôpitaux de Paris reporting completion of a study investigating kidney diseases, including …
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: 9-ING-41 in Patients With Advanced Cancers [Phase 2]
Actuate Therapeutics' Phase 2 trial of 9-ING-41 in patients with advanced cancers is currently active but not recruiting, with pancreatic ca…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours [Phase 1]
Clinical trial update describes a Phase 1 dose-escalation study of [225Ac]-FPI-2068 in adults with advanced solid tumors, currently recruiti…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCC [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the safety and efficacy of combining bicalutamide with sunitinib in patients with renal cell carcin…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers [Phase 1]
This Phase 1 trial evaluates gevokizumab in combination with standard-of-care anticancer therapies for metastatic colorectal cancer, gastroe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma [Phase 4]
This is a Phase 4 clinical trial update evaluating therapeutic drug monitoring of sunitinib and pazopanib in advanced or metastatic renal ce…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating Nanrilkefusp alfa alone and with pembrolizumab in adults with advanced or metastatic solid tumors; the study (NCT04…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC [Phase 2]
This Phase 2 trial evaluates WGI-0301 in combination with nivolumab in patients with hepatocellular carcinoma and renal cell carcinoma. The …
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer [Phase 1]
A Phase 1 study of PF-07921585 alone or with other anti-cancer medicines in multiple cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer [Phase 2]
A Phase 2 trial evaluating sitravatinib with nivolumab for advanced or metastatic clear cell renal cell carcinoma was terminated.
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
The NOTION study investigates in-home sampling of cytokines in cancer patients receiving immunotherapy, and the trial has completed. The con…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Symptomatic and Incidental RCC Detection
Completed clinical trial update focusing on symptomatic and incidental detection of renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies [Phase 1, Phase 2]
Phase 1/2 trial of plinabulin with radiation and immunotherapy in select advanced cancers after progression on PD-1/PD-L1 therapy was termin…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC [Phase 2]
A Phase 2 study evaluating adaptive immunotherapy with a VEGFR-TKI in patients with advanced renal cell carcinoma has been suspended.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Perioperative TORIPALIMAB Plus LENVATINIB in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PLUTO) [Phase 2]
The Phase 2 PLUTO trial evaluating perioperative toripalimab plus lenvatinib in renal cell carcinoma patients undergoing nephrectomy has bee…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011) [Phase 3]
A Phase 3 trial (MK-6482-011) compares belzutifan in combination with lenvatinib versus cabozantinib for renal cell carcinoma; the study is …
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001) [Phase 1, Phase 2]
Genmab's PRO1160 (GEN1160) Phase 1/2 trial in relapsed or refractory non-Hodgkin lymphoma has been terminated; the study also included renal…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies [Phase 1]
Phase 1 trial evaluating DFF332 as a single agent and in combination with Everolimus and immuno-oncology agents in advanced/relapsed renal c…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting
A completed real-world study evaluated how second-line axitinib (Inlyta) impacts outcomes for patients with metastatic renal cell carcinoma …
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Circulating and Urinary Exosomal miRNA as Predictors of Treatment Response in Advanced Kidney Cancer [NA]
A completed clinical trial evaluates circulating and urinary exosomal microRNA as predictors of treatment response in advanced renal cell ca…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).
Pfizer-sponsored trial evaluating first- and later-line therapies for metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines. [Phase 1]
Phase 1 study of PF-07826390 in cancer patients, including non-small cell lung cancer, was terminated; the trial evaluated different doses o…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of intravenous QEQ278 in patients with advanced solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors [Phase 1]
Phase I trial comparing HLX17 to Keytruda in multiple solid tumors to evaluate pharmacokinetics, preliminary efficacy, safety, and immunogen…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Circulating and Urinary Exosomal miRNA in Advanced Kidney Cancer (EXO-RENAL1) [NA]
This clinical trial update reports the completed status of the EXO-RENAL1 study evaluating circulating and urinary exosomal miRNA in advance…